EUVIMEDEUVIMED entdecken
Crossref

Rational Design of Poly(disulfide) Orchestrates Thiol‐Mediated and Light‐Driven siRNA Delivery for Cancer Immunotherapy

Zhenqiu Huang, Yapeng Xu, Xiaoqi Ming, Mingyu Wu, Shun Feng, Yu Wan iD

Advanced Healthcare Materials · 2026-04 · 15 (14)

DOI: 10.1002/adhm.202505724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.01.2026. Verfasst von Zhenqiu Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Disulfides, Immunotherapy, Sulfhydryl Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic siRNA application is limited by its endosomal entrapment and subsequent degradation. Here, we rationally develop a dual‐pathway polymeric carrier, PFCPD, by co‐assembling two functional cell‐penetrating poly(disulfide)s (CPDs): PCPD, bearing a photosensitizer, and FCPD, modified with a folate‐targeting ligand. This hybrid design enables efficient siRNA delivery by combining thiol‐mediated membrane penetration, which facilitates direct cytosolic transport via disulfide exchange at the cell surface, and photochemical internalization (PCI), allowing endocytosed complexes to escape from endo/lysosomes upon light‐triggered reactive oxygen species (ROS) generation. Simultaneously, intracellular glutathione (GSH) cleaves the polymer backbone to release siRNA and is consumed in the process, sensitizing cells to oxidative damage. When loaded with anti‐GPX4 siRNA (siGPX4), PFCPD induces potent ferroptosis by downregulating GPX4 and amplifying ROS stress under illumination. The combination of ferroptosis and type I photodynamic therapy synergistically triggers immunogenic cell death, promotes dendritic cell maturation, and activates CD8 + T cell‐mediated antitumor immunity in bilateral tumor models. This work presents a CPD‐based siRNA nanoplatform that uniquely integrates thiol‐mediated cytosolic entry with PCI‐assisted endosomal escape in a single system, addressing the trade‐off between tumor targeting and cytosolic accessibility. It offers a versatile strategy for siRNA delivery capable of achieving efficient cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingDisulfidesImmunotherapySulfhydryl CompoundsNeoplasmsAnimalsHumansReactive Oxygen SpeciesCell Line, TumorMiceLightPhotosensitizing AgentsPhotochemotherapy

Stichwörter der Autor:innen

cell‐penetrating poly(disulfide)sendosome escapeferroptosisphotochemical internalizationsiRNA delivery

Substanzen

RNA, Small InterferingDisulfidesReactive Oxygen SpeciesSulfhydryl CompoundsPhotosensitizing Agents

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
  • School of Biomedical Engineering, Sichuan University, Chengdu, China.

ORCID-Profile: Yu Wan

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Huang, Z., Xu, Y., Ming, X., Wu, M., Feng, S., & Wan, Y. (2026). Rational Design of Poly(disulfide) Orchestrates Thiol‐Mediated and Light‐Driven siRNA Delivery for Cancer Immunotherapy. Advanced Healthcare Materials, 15(14). https://doi.org/10.1002/adhm.202505724

Vancouver

Huang Z, Xu Y, Ming X, Wu M, Feng S, Wan Y. Rational Design of Poly(disulfide) Orchestrates Thiol‐Mediated and Light‐Driven siRNA Delivery for Cancer Immunotherapy. Advanced Healthcare Materials. 2026;15(14). doi:10.1002/adhm.202505724

BibTeX
@article{Huang2026,
  author = {Huang, Zhenqiu and Xu, Yapeng and Ming, Xiaoqi and Wu, Mingyu and Feng, Shun and Wan, Yu},
  title = {Rational Design of Poly(disulfide) Orchestrates Thiol‐Mediated and Light‐Driven siRNA Delivery for Cancer Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1002/adhm.202505724}
}
Kostenlos starten →